PuSH - Publikationsserver des Helmholtz Zentrums München

Hui, B.* ; Lu, C.* ; Li, H.* ; Hao, X.* ; Liu, H.* ; Zhuo, D.* ; Wang, Q. ; Li, Z.* ; Liu, L.* ; Wang, X.* ; Gu, Y.* ; Tang, W.*

Inhibition of APOE potentiates immune checkpoint therapy for cancer.

Int. J. Biol. Sci. 18, 5230-5240 (2022)
Verlagsversion Forschungsdaten DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
Checkpoint immunotherapy is capable of unleashing T cells for controlling tumor, whereas it is destroyed by immunosuppressive myeloid cell. Apoprotein E (APOE) refers to a ligand in terms of the members of low-density lipoprotein (LDL) receptor family for mediating Apoprotein B-involving atherogenic lipoprotein clearance. Besides, tumor-infiltration macrophage can express APOE. The present study reported Apoe-/- mice to exhibit higher resistance toward the development of three types of carcinomas as compared with mice with wild type and to have greater responses to αPD-1 (anti-PD-1) immunotherapy. Moreover, treatment by exploiting APOE inhibitor (COG 133TFA, αAPOE) was capable of curbing tumor development and fostering regression if in combination of αPD-1. According to single-cell RNA sequencing (scRNA-seq), Apoe deletion was correlated with the decline of C1QC+ and CCR2+ macrophage within tumor infiltration, and mass spectrometry results noticeably showed down-regulated the number of M2 macrophages as well. Furthermore, APOE expression in cancer patients resistant to αPD-1 treatment significantly exceeded that in the sensitive group. For this reason, APOE is likely to be targeted for modifying tumor macrophage infiltrate and augmenting checkpoint immunotherapy.
Altmetric
Weitere Metriken?
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Korrespondenzautor
Schlagwörter Apoe ; Macrophage ; Pd-1 ; Single-cell Rna Sequencing ; Tigit
ISSN (print) / ISBN 1449-2288
e-ISSN 1449-2288
Quellenangaben Band: 18, Heft: 14, Seiten: 5230-5240 Artikelnummer: , Supplement: ,
Nichtpatentliteratur Publikationen
Begutachtungsstatus Peer reviewed
Förderungen China Scholarship Council
National Natural Science Foundation of China